Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
UMBF compared with CRL: revenue, margins and what each company keeps, and the suppliers and customers both name
UMBF
UMB Financial Corp
Change
Mkt cap
Revenue
Revenue
CRL
Charles River Laboratories International, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
UMBF
UMB Financial Corp
vs
CRL
Charles River Laboratories International, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
UMBF: latest quarter not drawable. CRL: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only UMBF
2
BAC
BofA Securities
supplier
NDAQ
The NASDAQ Stock Market LLC (NASDAQ)
supplier
Shared
0
No shared counterparties.
Only CRL
2
CBIO
Crescent Biopharma
customer
CDT
CDT Equity
customer
Role chip = supplier or customer
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
UMBF, solid
CRL, dashed
UMBF
UMB Financial Corp
Change
134.51
▼
−1.22%
· post 134.07
Mkt cap
$10.2B
Revenue
$772M
Q3 FY26
Revenue
$2.7B
FY25
CRL
Charles River Laboratories International, Inc.
Change
358.17
▼
−4.77%
· post 361.00
Closed
Oct 30 '26
Mkt cap
$17.2B
Revenue
$1.0B
Q2 FY26
Revenue
$4.0B
FY25
vs
Compare
Closed
Oct 30 '26
UMBF
UMB Financial Corp
vs
CRL
Charles River Laboratories International, Inc.
134.51
▼
−1.22%
post 134.07
Price
358.17
▼
−4.77%
post 361.00
$10.2B
Mkt cap
$17.2B
Q3 FY26
$772M
Revenue
$1.0B
Q2 FY26
FY25
$2.7B
Revenue
$4.0B
FY25
Change
Change
UMBF
134.51
▼
−1.22%
vs
CRL
358.17
▼
−4.77%
Closed
Oct 30 '26